Foamix Pharmaceuticals Ltd.

Four biopharmaceutical companies launched initial public offerings during the first week of June, including China’s Legend Biotech Corp. with the biggest IPO so far in 2020. Eighteen drug developers

Menlo Therapeutics Inc. 's oral serlopitant failed a Phase II trial in chronic pruritus of unknown origin on 26 February, but more important data readouts for the neurokinin receptor 1 (NK1) antagonis

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Allergan Extends Its Aesthet

Here's your US review and approval news – a little earlier this week than usual: Vertex Pharmaceuticals Inc. received the go-ahead to launch its fourth cystic fibrosis treatment this week when the F